151 related articles for article (PubMed ID: 38285234)
1. Nasopharyngeal carcinoma: nationwide trends in subtype-specific incidence and survival over 3 decades in a non-endemic area.
van Velsen JS; van der Vegt B; Plaat BEC; Langendijk JA; Epskamp-Kuijpers CCHJ; van Dijk BAC; Oosting SF
J Cancer Res Clin Oncol; 2024 Jan; 150(2):49. PubMed ID: 38285234
[TBL] [Abstract][Full Text] [Related]
2. Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations.
Argirion I; Zarins KR; Suwanrungruang K; Pongnikorn D; Chitapanarux I; Sriplung H; Vatanasapt P; Rozek LS
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3291-3299. PubMed ID: 33247687
[TBL] [Abstract][Full Text] [Related]
3. A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma.
Ooft ML; van Ipenburg J; Braunius WW; Stegeman I; Wegner I; de Bree R; Overbeek LI; Koljenović S; Willems SM
Oral Oncol; 2016 May; 56():40-6. PubMed ID: 27086485
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population.
Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A
Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240
[TBL] [Abstract][Full Text] [Related]
5. Lower mortality from nasopharyngeal cancer in The Netherlands since 1970 with differential incidence trends in histopathology.
Arnold M; Wildeman MA; Visser O; Karim-Kos HE; Middeldorp JM; Fles R; Bing Tan I; Coebergh JW
Oral Oncol; 2013 Mar; 49(3):237-43. PubMed ID: 23089459
[TBL] [Abstract][Full Text] [Related]
6. Establishment and Characterization of an Epstein-Barr Virus-positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma.
Chai AWY; Yee SM; Lee HM; Abdul Aziz N; Yee PS; Marzuki M; Wong KW; Chiang AKS; Chow LK; Dai W; Liu TF; Tan LP; Khoo ASB; Lo KW; Lim PVH; Rajadurai P; Lightfoot H; Barthorpe S; Garnett MJ; Cheong SC
Cancer Res Commun; 2024 Mar; 4(3):645-659. PubMed ID: 38358347
[TBL] [Abstract][Full Text] [Related]
7. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
[TBL] [Abstract][Full Text] [Related]
8. A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.
Feng FT; Cui Q; Liu WS; Guo YM; Feng QS; Chen LZ; Xu M; Luo B; Li DJ; Hu LF; Middeldorp JM; Ramayanti O; Tao Q; Cao SM; Jia WH; Bei JX; Zeng YX
Chin J Cancer; 2015 Dec; 34(12):563-72. PubMed ID: 26675171
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review.
Chow JCH; Lee AWM; Wong CHL; Ng WT; Liu Z; Tay JK; Loh KS; Pace-Asciak P; Cohen O; Corry J; Rodrigo JP; Tsang RKY; Lopez F; Saba NF; de Bree R; Ferlito A
Oral Oncol; 2022 Oct; 133():106031. PubMed ID: 35908365
[TBL] [Abstract][Full Text] [Related]
10. Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities.
Lenoci D; Resteghini C; Serafini MS; Pistore F; Canevari S; Ma B; Cavalieri S; Alfieri S; Trama A; Licitra L; De Cecco L
Transl Res; 2024 Mar; 265():1-16. PubMed ID: 37949350
[TBL] [Abstract][Full Text] [Related]
11. Multiplex Epstein-Barr virus BALF2 genotyping detects high-risk variants in plasma for population screening of nasopharyngeal carcinoma.
Miller JA; Sahoo MK; Yamamoto F; Huang C; Wang H; Zehnder JL; Le QT; Pinsky BA
Mol Cancer; 2022 Jul; 21(1):154. PubMed ID: 35902864
[TBL] [Abstract][Full Text] [Related]
12. Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediation.
Xu M; Feng R; Liu Z; Zhou X; Chen Y; Cao Y; Valeri L; Li Z; Liu Z; Cao SM; Liu Q; Xie SH; Chang ET; Jia WH; Shen J; Yao Y; Cai YL; Zheng Y; Zhang Z; Huang G; Ernberg I; Tang M; Ye W; Adami HO; Zeng YX; Lin X
Cell Genom; 2024 Feb; 4(2):100474. PubMed ID: 38359790
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
Guo J; Cui Z; Zheng Y; Li X; Chen Y
Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
Ruuskanen M; Irjala H; Minn H; Vahlberg T; Randen-Brady R; Hagström J; Syrjänen S; Leivo I
Head Neck; 2019 Feb; 41(2):349-357. PubMed ID: 30549170
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus detection in nasopharyngeal carcinoma: implications in a low-risk area.
Breda E; Catarino RJ; Azevedo I; Lobão M; Monteiro E; Medeiros R
Braz J Otorhinolaryngol; 2010; 76(3):310-5. PubMed ID: 20658009
[TBL] [Abstract][Full Text] [Related]
16. An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation.
Xu FH; Xiong D; Xu YF; Cao SM; Xue WQ; Qin HD; Liu WS; Cao JY; Zhang Y; Feng QS; Chen LZ; Li MZ; Liu ZW; Liu Q; Hong MH; Shugart YY; Zeng YX; Zeng MS; Jia WH
J Natl Cancer Inst; 2012 Sep; 104(18):1396-410. PubMed ID: 22972969
[TBL] [Abstract][Full Text] [Related]
17. BART-D2 subtype of EBV encoded BART miRNA cluster 1 region is strongly associated with endemic nasopharyngeal carcinoma.
Wang Q; He H; Ji X; Liu Y; Li H; Wang Y
J Med Virol; 2023 Mar; 95(3):e28667. PubMed ID: 36912378
[TBL] [Abstract][Full Text] [Related]
18. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan.
Kano M; Kondo S; Wakisaka N; Moriyama-Kita M; Nakanishi Y; Endo K; Murono S; Nakamura H; Yoshizaki T
Auris Nasus Larynx; 2017 Jun; 44(3):327-332. PubMed ID: 27499435
[TBL] [Abstract][Full Text] [Related]
19. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.
Ruuskanen M; Leivo I; Minn H; Vahlberg T; Haglund C; Hagström J; Irjala H
BMC Cancer; 2019 Jun; 19(1):624. PubMed ID: 31238894
[TBL] [Abstract][Full Text] [Related]
20. [Epstein-Barr virus (Herpesviridae:
Smirnova KV; Lubenskaya AK; Senyuta NB; Dushenkina TE; Gurtsevitch VE
Vopr Virusol; 2023 Sep; 68(4):291-301. PubMed ID: 38156586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]